BioSpace News Archive

Biotech Beach

MDxHealth: Shareholder Transparency Declaration

MDxHealth today announced that, that it received the following notification of significant shareholdings, in conformity with Article 15 of the Belgian Act of May 2, 2007 on the publication of significant shareholdings in issuers which shares are admitted to trading on a regulated market.

January 17, 2018
·
2 min read
Drug Development

Gemphire Completes Patient Enrollment in INDIGO-1 Trial in Severe Hypertriglyceridemia (SHTG) Patients

The Company remains on track to report top-line results from the study in the second quarter of 2018.

January 17, 2018
·
9 min read
Business

Orchard Therapeutics Appoints Frank Thomas as Chief Financial Officer and Chief Business Officer

Orchard Therapeutics today announced the appointment of Frank Thomas to the newly created position of CFO and CBO.

January 17, 2018
·
3 min read
Drug Development

Amarin Announces Commencement of VASCEPA Clinical Development in Mainland China

Under the parties’ February 2015 agreement, Eddingpharm is responsible for Vascepa development, regulatory activities, commercialization and associated costs, including managing and funding this pivotal registration study.

January 17, 2018
·
8 min read
MDxHealth: Shareholder Transparency Declaration - Jan. 17, 2018

Capfi Delen Asset Management is a Belgian Management Company of UCITS. For further information, reference is made to the information published on MDxHealth’s website.

January 17, 2018
·
3 min read
Genetown

PathMaker Neurosystems Receives Award from Non-Profit Consortium to Support Development of MyoAmplifier for the Non-Invasive Treatment of Pediatric Paralysis and Muscle Weakness

The funding and in-kind services provided by the NEPDC will support development of PathMaker’s MyoAmplifier system, an advanced non-invasive platform that treats patients with paralysis and muscle weakness.

January 17, 2018
·
3 min read
Innovative Antibody Production: Helmholtz Association Funding Spin-Off

The Helmholtz Association is funding a new Helmholtz Zentrum München spin-off with roughly 115,000 euros.

January 17, 2018
·
5 min read
BioMidwest

AveXis Announces Pricing of Public Offering of Common Stock - Jan. 17, 2018

The offering is expected to close on or about January 19, 2018, subject to customary closing conditions.

January 17, 2018
·
3 min read
Business

Biogennix Reports Record Growth for 2017; Expands Executive Management Team

The company closed the year with 47% growth, the broadest increase the company has experienced in its history.

January 17, 2018
·
3 min read
Business

Synteract Adds Karl Deonanan as Chief Financial Officer to Take Company Into Next Phase of Growth

Deonanan joins Synteract from IQVIA (formerly Quintiles) where he was CFO of the organization’s Research and Development Solutions segment.

January 17, 2018
·
2 min read